Viking Therapeutics CEO Brian Lian's 2019 pay jumps 150% to $3.5M
Viking Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 6, 2020
Viking Therapeutics reported fiscal year 2019 executive compensation information on April 6, 2020.
In 2019, two executives at Viking Therapeutics received on average a compensation package of $2.2M, a 120% increase compared to previous year.
Average pay of disclosed executives at Viking Therapeutics
Brian Lian, Chief Executive Officer, received $3.5M in total, which increased by 150% compared to 2018. 44% of Lian's compensation, or $1.5M, was in stock awards. Lian also received $210K in non-equity incentive plan, $1.2M in option awards, as well as $525K in salary.
Hiroko Masamune, Former Chief Development Officer, received a compensation package of $906K, which decreased by 9% compared to previous year. 39% of the compensation package, or $349K, was in option awards.
Related executives
You may also like
Source: SEC filing on April 6, 2020.